Filing Details
- Accession Number:
- 0001209191-23-004285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-20 16:36:45
- Reporting Period:
- 2023-01-18
- Accepted Time:
- 2023-01-20 16:36:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679082 | Myovant Sciences Ltd. | MYOV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712069 | Matthew Lang | C/O Myovant Sciences Inc. 2000 Sierra Point Parkway, 9Th Floor Brisbane CA 94005 | General Counsel & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-01-18 | 1,272 | $26.89 | 354,303 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Billionaire Hedge Funds
